Koshlan Mayer-Blackwell
Overview
Explore the profile of Koshlan Mayer-Blackwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minot S, Mayer-Blackwell K, Fiore-Gartland A, Johnson A, Self S, Bhatti P, et al.
Gut Microbes
. 2024 Oct;
16(1):2414975.
PMID: 39428758
Background: The human gut microbiome develops rapidly during infancy, a key window of development coinciding with the maturation of the adaptive immune system. However, little is known about the microbiome...
2.
Church E, Bishop E, Fiore-Gartland A, Yu K, Chang M, Jones R, et al.
Immunohorizons
. 2024 Sep;
8(9):695-711.
PMID: 39283647
Cutaneous mycobacterial infections cause substantial morbidity and are challenging to diagnose and treat. An improved understanding of the dermal immune response to mycobacteria may inspire new therapeutic approaches. We conducted...
3.
Ford E, Li A, Laing K, Dong L, Diem K, Jing L, et al.
JCI Insight
. 2024 Aug;
9(14).
PMID: 39133650
The skin at the site of HSV-2 reactivation is enriched for HSV-2-specific T cells. To evaluate whether an immunotherapeutic vaccine could elicit skin-based memory T cells, we studied skin biopsies...
4.
Glass D, Mayer-Blackwell K, Ramchurren N, Parks K, Duran G, Wright A, et al.
Cell Rep Med
. 2024 Apr;
5(5):101527.
PMID: 38670099
Cutaneous T cell lymphomas (CTCLs) are skin cancers with poor survival rates and limited treatments. While immunotherapies have shown some efficacy, the immunological consequences of administering immune-activating agents to CTCL...
5.
Ryu H, Bi T, Pulliam T, Sarkar K, Church C, Kumar N, et al.
Cell Rep Med
. 2024 Feb;
5(2):101390.
PMID: 38340724
Merkel cell carcinoma is a skin cancer often driven by Merkel cell polyomavirus (MCPyV) with high rates of response to anti-PD-1 therapy despite low mutational burden. MCPyV-specific CD8 T cells...
6.
Minot S, Mayer-Blackwell K, Fiore-Gartland A, Johnson A, Self S, Bhatti P, et al.
medRxiv
. 2024 Jan;
PMID: 38168439
Background: The human gut microbiome develops rapidly during infancy, a key window of development coinciding with maturation of the adaptive immune system. However, little is known of the microbiome growth...
7.
Ford E, Mayer-Blackwell K, Jing L, Laing K, Sholukh A, St Germain R, et al.
Nat Immunol
. 2023 Dec;
25(1):166-177.
PMID: 38057617
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hybrid immunity is more protective than vaccination or previous infection alone. To investigate the kinetics of spike-reactive T (T) cells from SARS-CoV-2 infection...
8.
Johnson A, Hager K, Alameh M, Van P, Potchen N, Mayer-Blackwell K, et al.
J Immunol
. 2023 Oct;
211(11):1680-1692.
PMID: 37850965
Nucleic acid vaccines, including both RNA and DNA platforms, are key technologies that have considerable promise in combating both infectious disease and cancer. However, little is known about the extrinsic...
9.
Mayer-Blackwell K, Ryu H, Codd A, Parks K, MacMillan H, Cohen K, et al.
Cell Rep Med
. 2023 Aug;
4(8):101149.
PMID: 37552991
SARS-CoV-2 infection and mRNA vaccination both elicit spike (S)-specific T cell responses. To analyze how T cell memory from prior infection influences T cell responses to vaccination, we evaluated functional...
10.
Johnson A, Hager K, Alameh M, Van P, Potchen N, Mayer-Blackwell K, et al.
bioRxiv
. 2023 Feb;
PMID: 36824851
Nucleic acid vaccines, including both RNA and DNA platforms, are key technologies that have considerable promise in combating both infectious disease and cancer. However, little is known about the extrinsic...